Parent Page: Academic Departments id: 22046 Active Page: Faculty - Staffid:22079

Faculty and Staff


Priyabrata Mukherjee, PhD, FRSC

Priyabrata Mukherjee, PhD, FRSC, FAIMBE, FNAI

PHF Presidential Professor

Associate Director of Translational Research, Stephenson Cancer Center

Peggy and Charles Stephenson Endowed Chair in Laboratory Cancer Research

Professor of Pathology

Co-Director, Nanomedicine Program, Stephenson Cancer Center

Oklahoma TSET Research Scholar

The University of Oklahoma Health Sciences Center
975 NE 10th ST, BRC 1409A
Oklahoma City, OK 73104



  • University of Burdwan
    BS, Chemistry, 1992
  • University of Burdwan
    MS, Chemistry, 1994
  • University of Poona
    PhD, Chemistry, 2000


  • Council of Scientific Industrial Research
    Junior Research Fellow, 1996
  • Council of Scientific Industrial Research
    Senior Research Fellow, 2000
  • Texas Christian University
    Fort Worth, TX
    Postdoctoral Fellow, 2004
  • Harvard Medical School/Children's Hospital
    Boston, MA
    Research Fellow, 2004
  • Mayo Clinic
    Rochester, MN
    Senior Research Fellow, 2005

Clinical/Research Interests:

  • Reprogramming tumor microenvironment by nanoparticles
  • Anti-Angiogenic property of inorganic nanoparticles
  • Metabolic enzyme and angiogenesis
  • Identification of new molecular targets using nanotechnology
  • Nanoendocytosis
  • Understanding cellular processes using engineered nanoparticles
  • Metabolic enzymes in cancer

Select Publications:

  1. Bhattacharyya S, Bhattacharya R, Curley S, McNiven MA, Mukherjee P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14541-6. doi: 10.1073/pnas.1006507107. Epub 2010 Aug 2.
  2. Bhattacharyya S, Khan S, Curran G, Robertson JD, Bhattacharya R, Mukerjee P. Efficient delivery of gold nanoparticles by dual receptor targeting. Angew Chem. 2011 Nov 16;23(43):5034-5038. DOI: 10.1002/adma.201102287.
  3. Arvizo RR, Saha S, Wang E, Robertson JD, Bhattacharya R, Mukherjee P. Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6700-5. doi: 10.1073/pnas.1214547110. Epub 2013 Apr 8.
  4. Saha S, Xiong X, Chakraborty PK, Shameer K, Arvizo RR, Kudgus RA, Dwivedi SK, Hossen MN, Gillies EM, Robertson JD2, Dudley JT1, Urrutia RA, Postier RG, Bhattacharya R, Mukherjee P. Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. ACS Nano. 2016 Dec 27;10(12):10636-10651. doi: 10.1021/acsnano.6b02231. Epub 2016 Oct 19.
  5. Chakraborty PK, Mustafi SB, Xiong X, Dwivedi SKD, Nesin V, Saha S, Zhang M, Dhanasekaran D, Jayaraman M, Mannel R, Moore K, McMeekin S, Yang D, Zuna R, Ding K, Tsiokas L, Bhattacharya R, Mukherjee P. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 May 22;8:14634. doi: 10.1038/ncomms14634.
  6. Hossen MN, Rao G, Dey A, Robertson JD, Bhattacharya R, Mukherjee P.  Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.  ACS Appl Mater Interfaces. 2019 Jul 24;11(29):26060-26068. doi: 10.1021/acsami.9b03313. Epub 2019 Jul 11.
  7. Huai Y, Zhang Y, Xiong X, Das S, Bhattacharya R, Mukherjee P. Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine.  Cell Stress. 2019 Jul 31;3(8):267-279. doi: 10.15698/cst2019.08.195.Cell Stress. 2019. PMID: 31440741
  8. Huai Y, Hossen MN, Wilhelm S, Bhattacharya R, Mukherjee P. . Nanoparticle Interactions With the Tumor Microenvironment.  Bioconjug Chem. 2019 Sep 18;30(9):2247-2263. doi: 10.1021/acs.bioconjchem.9b00448. Epub 2019 Sep 5.Bioconjug Chem. 2019. PMID: 31408324.
  9. Elechalawar CK, Hossen MN, McNally L, Bhattacharya R, Mukherjee P. Analysing the Nanoparticle-Protein Corona for Potential Molecular Target Identification  J Control Release. 2020 Jun 10;322:122-136. doi: 10.1016/j.jconrel.2020.03.008. Epub 2020 Mar 9.J Control Release. 2020. PMID: 32165239.
  10. Murphy B, Bhattacharya R, Mukherjee P. Hydrogen sulfide signaling in mitochondria and disease..  FASEB J. 2019 Dec;33(12):13098-13125. doi: 10.1096/fj.201901304R. Epub 2019 Oct 24.

Adjunct Faculty

Prabir K. Chakraborty, PhD

Prabir K. Chakraborty, PhD

Assistant Professor (Research)

Daniel J. Cowden, MD, FCAP, CPHIMS

Daniel J. Cowden, MD, FCAP, CPHIMS

Clinical Associate Professor

Charles Esmon, PhD

Charles Esmon, PhD

Lloyd Noble Chair, Cardiovascular Research

Member & Head, Cardiovascular Biology Research at OMRF

Adjunct Professor, Pathology

Adjunct Professor, Biochemistry

Investigator at Howard Hughes Medical Institute

David M Lewis, DDS

David M. Lewis, DDS

Associate Professor
Department of Oral and Maxillofacial Pathology

Adjunct Associate Professor
Department of Pathology

Yuechueng Liu, PhD

Yuechueng Liu, PhD

Associate Professor of Pathology

Jeffrey McBride, MD, PhD

Jeffrey McBride, MD, PhD

Assistant Professor


Adjunct Faculty - Pathology

Charles A. Montgomery, DVM, DACVP, DACLAM

Charles A. Montgomery, DVM, DACVP, DACLAM

Adjunct Professor
Department of Pathology
Division of Comparative Medicine

Kathy L. Moser, PhD

Kathy L. Moser, PhD

Associate Member, Arthritis & Immunology Program

Adjunct Faculty, Pathology

Aravindan Natarajan

Aravindan Natarajan, MS., MPhil., PhD., CCA.

Associate Professor, Department of Radiation Oncology,
Associate Professor (Adjunct), Department of Anesthesiology,
Associate Professor (Adjunct), Department of Pathology
Course Director, Radiation Biology for Radiation Oncology Residents
Graduate Faculty, College of Medicine
Member, Cancer Biology Program

Amr H. Sawalha, MD

Amr H. Sawalha, MD

Assistant Member
Arthritis and Immunology Research Program

Assistant Professor of Medicine 
Department of Medicine

Staff Physician 
Veteran Affairs Medical Center
Oklahoma City

Adjunct Faculty
Department of Pathology